Evaluation of a Novel Osteoporotic Drug Delivery System In Vitro: Alendronate-Loaded Calcium Phosphate Cement
Authors:
- Tang HaiTHTang Hai
- Gu JunchaoGJGu Junchao
- Wang BoWBWang Bo
- Bao LiBLBao Li
- Wang Bing QiangWQWang Bing Qiang
- 11 August 2010
- journal article
- research article
- Published by SLACK, Inc. in Orthopedics
- Vol. 33 (8)
Abstract
As a new drug delivery system, calcium phosphate cement was fabricated with different concentrations of alendronate (2, 5, 10 wt%), which is widely used to treat diseases related to bone loss. This study investigated the properties of the novel composite alendronate-loaded calcium phosphate cement in vitro, and found that the structure and chemical properties of the composites were not different from the calcium phosphate cement. However, the calcium phosphate cement set time was significantly faster compared with other groups ( P <.01), and the strength of the calcium phosphate cement was significantly greater than the other groups ( P <.01). The alendronate release rate from the composite increased with increase in drug concentration in the cement, and release was sustained over 21 days. The composite showed good biocompatibility in terms of the proliferation of rat mesenchymal stem cells. The alendronate-loaded calcium phosphate cement displayed satisfactory properties in vitro, which may be of benefit locally for osteoporotic bone in vivo.Keywords
This publication has 38 references indexed in Scilit:
- Bioavailability and bioequivalence of two oral formulations of alendronate sodium 70 mg: An open-label, randomized, two-period crossover comparison in healthy Korean adult male volunteersClinical Therapeutics, 2009
- Alendronate and Pamidronate calcium phosphate bone cements: Setting properties and in vitro response of osteoblast and osteoclast cellsJournal of Inorganic Biochemistry, 2009
- Giant Osteoclast Formation and Long-Term Oral Bisphosphonate TherapyNew England Journal of Medicine, 2009
- Safety Considerations with Bisphosphonates for the Treatment of OsteoporosisDrug Safety, 2007
- Randomized Active and Placebo-Controlled Endoscopy Study of a Novel Protected Formulation of Oral AlendronateDigestive Diseases and Sciences, 2006
- High-performance liquid chromatography method for determining alendronate sodium in human plasma by detecting fluorescence: Application to a pharmacokinetic study in humansJournal of Pharmaceutical and Biomedical Analysis, 2006
- Bisphosphanates and Oral Cavity Avascular Bone NecrosisJournal of Clinical Oncology, 2003
- A novel skeletal drug delivery system using self-setting calcium phosphate cement VIII: the relationship between in vitro and in vivo drug release from indomethacin-containing cementJournal of Controlled Release, 1997
- Stoichiometry of K+- and CO32--Containing Apatites Prepared by the Hydrolysis of Octacalcium PhosphateInorganic Chemistry, 1996
- A 20-Year Perspective on the Mechanical Properties of Trabecular BoneJournal of Biomechanical Engineering, 1993